AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05735561 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: X-Ray
Description: Consenting participants will be asked to come into the clinic for a single visit, during this visit they will be asked to complete an x-ray to check for evidence of avascular necrosis.
Study NCT06423911 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: olverembatinib
Description: olverembatinib QOD
Study NCT06423911 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Bosutinib
Description: Bosutnib QD
Study NCT05825898 — intervention group
Intervention type: PROCEDURE
Intervention: Surgery or Transcatheter tricuspid valve intervention
Description: Isolated tricuspid valve surgery or Transcatheter tricuspid valve intervention
Study NCT05415696 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Prostatic artery embolization
Description: Patients will undergo PAE with 100-300 µm or 300-500 µm Embospheres following standard PAE technique performed by Interventional Radiology at Stanford University
Study NCT05507983 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: Tranexamic acid 1500 mg
Study NCT05639556 — intervention group
Intervention type: OTHER
Intervention: 12-month Questionnaire
Description: A short questionnaire designed to explore participants' perspectives of the acceptability and feasibility of nutritional assessments used in STRONG-CF will be given to all study participants at the end of the study.
Study NCT05507983 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, sodium chloride 0.9%
Study NCT05639556 — intervention group
Intervention type: OTHER
Intervention: Oral glucose tolerance testing (OGTT)
Description: For subjects without previously diagnosed CFRD, an OGTT will be performed at baseline and 12-months with samples analyzed at the central lab.
Study NCT05639556 — intervention group
Intervention type: DEVICE
Intervention: Continuous glucose monitoring (CGM)
Description: Subjects will wear a Dexcom G6Pro sensor in blinded mode for three 10-day periods to collect comprehensive glucose data.
Study NCT05639556 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Chest CT scans (When available within the past 6 months in medical records)
Description: Standard of Care chest CT images will be drawn from the medical record, as available, from enrolled participants. FEV1 measurements prior to chest CT scans will be recorded to account for possible illness occurring at the time of scanning. Quantitative assessment of the pectoralis muscle area will be performed on the first single axial image above the aortic arch. Any additional standard of care chest CT's that are performed while the participant is enrolled in the study will also be collected and have a quantitative assessment of the pectoralis muscle performed.
Study NCT06165796 — intervention group
Intervention type: DEVICE
Intervention: routine cataract surgery and intraocular lens implantation
Description: routine cataract surgery and intraocular lens implantation
Study NCT06321133 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High flow nasal cannula immediate ending
Description: High flow is immediately ended
Study NCT06321133 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High flow nasal cannula weaning
Description: High flow is gradually weaned by reducing the flow rate
Study NCT05783635 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Enhanced Usual Care (pre-operative)
Description: The enhanced usual care will receive standard surgical care, and a resource brochure including basic information on health, alcohol use withdrawal risks, and treatment/emergency resources. The resource brochure will be e-mailed to patients or sent via postal mail.
Study NCT05783635 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Usual Care (pre-operative)
Description: The enhanced usual care will receive standard surgical care, and a resource brochure including basic information on health, alcohol use withdrawal risks, and treatment/emergency resources. The resource brochure will be e-mailed to patients or sent via postal mail.
Study NCT05783635 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Preoperative Virtual Health Coaching
Description: Preoperative Virtual Coaching is based on principles of health coaching, collaborative care, and motivational interviewing. Health and educational content is framed using the Health Belief Model. During two sessions, that take place approximately 3 and 5 weeks prior to surgery, the health coach presents alcohol use reduction/abstinence as important for surgical health (rather than addiction or chronic health reasons) and engages participants in discussion and patient-centered goal-setting.~Participants will also receive a brochure including basic information on health, alcohol use withdrawal risks, and treatment/emergency resources.
Study NCT05783635 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preoperative Virtual Health Coaching
Description: Preoperative Virtual Coaching is based on principles of health coaching, collaborative care, and motivational interviewing. Health and educational content is framed using the Health Belief Model. During two sessions, that take place approximately 3 and 5 weeks prior to surgery, the health coach presents alcohol use reduction/abstinence as important for surgical health (rather than addiction or chronic health reasons) and engages participants in discussion and patient-centered goal-setting.~Participants will also receive a brochure including basic information on health, alcohol use withdrawal risks, and treatment/emergency resources.
Study NCT05783635 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Usual surgical care (post-operative)
Description: This group will receive standard post-operative care.
Study NCT05783635 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Postoperative Virtual Health Coaching
Description: Postoperative Virtual Coaching uses the same framework and structure as Preoperative Virtual Coaching. These sessions will be delivered by a health coach using a collaborative, and motivational interviewing-based approach. The goal of these sessions is to promote well-being and help participants maintain alcohol abstinence or reduction long-term (or initiate change in alcohol use if they have not already). These sessions promote low-risk alcohol use, provide education on chronic health effects of heavy alcohol use, and teach skills for coping with or avoiding triggers for alcohol use including coping with stress and mood challenges. These sessions introduce skills to help participants manage alcohol, stress, and mood as they recover from surgery.
Study NCT05783635 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: On-Track (Post-operative)
Description: On-Track is a mobile and web-accessible health tool that uses self-monitoring and provision of feedback on progress towards goals to engage participants in self-management of alcohol use and motivate behavior change through increased self-awareness and accountability for health.~The On-Track application includes a) daily tracking of alcohol and other substance use; b) daily tracking of stress, mood, and pain; c) personalized health goals; and d) visual displays of alcohol use, stress, mood, pain, and goal achievement including graphs of trends over time.~On-Track also uses novel monetary and non-monetary incentives to encourage utilization including an escalating monetary incentive schedule for self-monitoring.
Study NCT06022185 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Web Based Training on E-health Literacy, Digital Literacy and Healthy Lifestyle Behaviors.
Description: In the trainings planned for elderly individuals, digital literacy and e-health literacy levels will be improved, knowledge and awareness levels of elderly individuals will be increased and they will be provided with information in this direction. healthy lifestyle behaviors.~Personal information form, E-Health Literacy Scale, Acquisition and Confirmation of Health Information in Digital Environment Scale, Healthy Lifestyle Behaviors Scale-II will be used in the research.
Study NCT05339139 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Dialysis
Description: In this study critically ill adult patients requiring Continuous Renal Replacement Therapy (CRRT) will receive Regional Citrate Anticoagulation (CRA) which will be delivered by multiFiltratePRO system.
Study NCT04578249 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blue light-blocking goggles
Description: Participants will be randomly assigned to one of the two intervention groups.
Study NCT04578249 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Clear goggles
Description: Participants will be randomly assigned to one of the two intervention groups.
Study NCT04988217 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Interferon-Alpha2B
Description: Nebulized interferon alpha 2B
Study NCT04988217 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Nebulized placebo
Study NCT06342843 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total Hip Arthroplasty
Description: a surgical procedure in which an orthopaedic surgeon removes the damaged bone and cartilage and replaces this with prosthetic components.
Study NCT05212077 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Advanced Care at Home (ACH)
Description: Inpatient hospitalization offered in the home setting.
Study NCT05212077 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Brick-and-Mortar Hospitalization
Description: Inpatient hospitalization offered in the hospital setting.
Study NCT06278896 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cessation of antibiotics
Description: Stop antibiotic therapy after episode of fever if afebrile for 48 hours, no clinically documented source of bacterial infection, and no hemodynamic or respiratory decompensation.
Study NCT04599478 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naltrexone and Bupropion medication
Description: NB medication will be taken daily in pill form.
Study NCT05639556 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hologic Dual X-Ray Absorptiometry (DXA)
Description: DXA measurements for whole body, total hip and lumbar spine will be acquired using the Hologic DXA and standard positioning as noted in the DXA Manual of Operations. DXA will be used to estimate total and regional body composition, which will include body fat and lean body mass. This will be used as the gold standard from which to validate BIA and MAMC.
Study NCT05639556 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound Sub-study of assessment of appendage muscles using ultrasound
Description: A minimum of 50 individuals will be enrolled. At each study visit, participants will undergo ultrasound muscle measurements (cross-sectional area and muscle thickness) of the biceps and quadriceps on each (left and right) side of the body (4 total areas). These measurements will be obtained in triplicate for each patient.
Study NCT05639556 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Psychosocial questionnaire: Hunger Vital Sign questionnaire
Description: Screening tool for identifying households at risk of food insecurity and poor health outcomes linked to food insecurity with 3-items over the last 12 months.
Study NCT05043389 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: myofunctional therapy program
Description: Exercise oral cavity muscle
Study NCT04747587 — intervention group
Intervention type: OTHER
Intervention: Reaching Session
Description: Two x 45 minutes sessions of reaching tasks. Patients in the stroke group will perform the task with the paretic arm using a weight reduction system, allowing movement in the horizontal plane.~Subjects in the control group will perform the task with the randomly selected arm weighted at 80% of their maximum voluntary shoulder torque
Study NCT05185050 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: physical examination and measurement of spinal alignment
Description: physical examination for scoliosis and myofascial pain syndrome, measurement of spinal coronal and sagittal alignment in X-ray, and pain intensity (with Visual analog scale) if necessary (for MPS group)
Study NCT05003596 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone Tablet
Description: Subjects will take a quantity 21 4mg tablets over a 6 week taper.
Study NCT05003596 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Mobilization Treatment
Description: standard treatment of hand injuries with focus on mobilization. No anti-inflammatory medications. Pain management via Tylenol or narcotics if deemed necessary.
Study NCT04880369 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Soy isoflavones
Description: Commercially available dietary supplement (capsule) containing 60 mg isoflavones (genistein, daidzein and glycitein).
Study NCT04880369 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lignans
Description: Commercially available dietary supplement (capsule) containing 63 mg lignans (secoisolaricirecinol)
Study NCT04599478 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Weight Loss
Description: Behavioral Weight Loss (BWL) counseling includes weekly sessions.
Study NCT04599478 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be inactive and taken daily in pill form.
Study NCT04599478 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be inactive and taken daily in pill form.
Study NCT04880369 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo capsules are supplied and packaged by Region Hovedstadens Apotek (Denmark) and will contain lactose monohydrate, potato starch, gelatin, magnesium stearate and talc.
Study NCT06141265 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Niraparib
Description: The starting dose is 300mg or 200mg QD based on the subject's baseline body weight or baseline platelet count
Study NCT05179525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Risperidone ISM® 100 mg
Description: 100 mg of risperidone ISM® administered every 4 weeks
Study NCT05179525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Risperdal 4mg Tablet
Description: 4 mg oral risperidone once daily for 7 days
Study NCT05639556 — intervention group
Intervention type: OTHER
Intervention: Respiratory symptom questionnaire: CRISS
Description: Chronic Respiratory Infection Symptom Score (CRISS) is an 8-item respiratory symptom questionnaire covering the last 24-hours.
Study NCT05494047 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tetravalent influenza vaccine developed by Sinovac Biotech Co.
Description: 15μg Hemagglutinin Antigen (HA) of each of the four strains
Study NCT05494047 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tetravalent influenza vaccine developed by Sinovac Biotech Co.
Description: 15μg Hemagglutinin Antigen (HA) of each of the four strains
Study NCT04511858 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: maximum effort test on a cycloergometer
Description: 5 h test on cycloergometer
Study NCT04511858 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: maximum effort test on a treadmill
Description: 5 h test on treadmill
Study NCT05165758 — intervention group
Intervention type: OTHER
Intervention: Self-assessment questionnaires
Description: Subjects will pass the SF-36 score (mental health items) and the EPICES index
Study NCT04918511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OPD5
Description: OPD5 solution for i.v. infusion
Study NCT05374551 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Transcranial magnetic stimulation
Description: Transcranial magnetic stimulation will be used to stimulate brain activity in a brain region of experimental interest (lateral parietal cortex) and in a control brain region (vertex). All participants will experience both forms of stimulation, in separate sessions. Stimulation will be applied as a probe to understand the basic phenomenon of how brain processes support episodic memory.
Study NCT05745519 — intervention group
Intervention type: OTHER
Intervention: Pittsburgh sleep quality index (PSQI)
Description: The scale is suitable for the evaluation of sleep quality in patients with sleep disorders and mental disorders, as well as for the evaluation of sleep quality in general people.
Study NCT05745519 — intervention group
Intervention type: DEVICE
Intervention: ANSWatch
Description: Measure eight physiological parameters including heartbeat, systolic blood pressure, diastolic blood pressure, heart rhythm variability HRV, low frequency component LF, high frequency component HF, LF/HF low frequency high frequency component ratio, and irregular heartbeat within five minutes
Study NCT05639556 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Spirometry
Description: Spirometry will be performed in accordance with the current American Thoracic Society recommendations for the performance and interpretation of tests.
Study NCT05639556 — intervention group
Intervention type: OTHER
Intervention: Psychosocial questionnaire: Additional Health Questionnaire
Description: Single question over the last 3 months/90 days about cannabis use for GI problems and appetite. The clinical sites will not see the responses to this question. It will be completed by the participant online either during the study visit or at home.
Study NCT05465291 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise group
Description: This group will receive passive/active range of motion (ROM) exercises. ROM exercises will include major muscle groups (i.e. biceps, triceps, and lower limbs) and will be applied from second day till seventh day of admission .
Study NCT05465291 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Muscle Stimulation group
Description: * Patients in NEMS group will receive neuromuscular electrical stimulation from second day till seventh day of admission.~* Neuromuscular electrical stimulation will be implemented simultaneously on the rectus femoris, vastus lateralis, and vastus medialis muscles of both lower limbs, with two stimulators, in two 30-min sessions per day starting from the second day till seventh day of admission .
Study NCT05049174 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nuse-led interview and referral to municipal healthy life-centres
Description: Usual care treatment and written information to patients and general practitionnaires about smoking cessation and the municipal healthy life-centres
Study NCT05049174 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nuse-led interview and referral to municipal healthy life-centres
Description: Usual care treatment and written information to patients and general practitionnaires about smoking cessation and the municipal healthy life-centres
Study NCT05465291 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Muscle Stimulation and Exercise group
Description: Patients in this group will be subjected to Neuromuscular Electrical Muscle Stimulation and Exercise.
Study NCT04784559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Plitidepsin
Description: Plitidepsin 2 mg powder is provided as a sterile, preservative-free, and white to off-white lyophilised powder/cake comprising 2 mg plitidepsin and mannitol in a single-dose, 10 mL clear type 1 glass vial.~Solvent for plitidepsin is provided as a sterile, preservative-free, clear, slightly viscous aqueous liquid (4 mL) containing macrogolglycerol ricinoleate and ethanol in a single-dose type 1 clear glass ampoule.~For administration, vial contents are reconstituted by addition of 4 mL of solvent for plitidepsin to obtain a slightly yellowish solution containing 0.5 mg/mL plitidepsin with mannitol, macrogolglycerol ricinoleate and ethanol excipients. The required amount of plitidepsin reconstituted solution is added to bag containing 0.9% sodium chloride or 5% glucose for IV injection and administered as an IV infusion over 60 minutes.
Study NCT06582381 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Meal set A
Description: morning meal: low carbohydrate, low protein, low fat afternoon meal: high carbohydrate, high protein, high fat
Study NCT06582381 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Meal set B
Description: morning meal: low carbohydrate, high protien, low fat meal afternoon meal: high carbohydrate, low protein, high fat meal
Study NCT06582381 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Meal set C
Description: morning meal: low carbohydrate, low protien, low fat meal afternoon meal: high carbohydrate, high protein, low fat meal
Study NCT06582381 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Meal set D
Description: morning meal: high carbohydrate, low protien, low fat meal afternoon meal: low carbohydrate, high protein, high fat meal
Study NCT06581380 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JK-1201I
Description: JK-1201I will be administered as an IV infusion at dose of 180mg/m2 on Day 1 of each 21-day cycle.
Study NCT06581380 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topotecan
Description: Topotecan will be administered per drug label.
Study NCT06582017 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: QXL138AM Injection every 2 weeks by IV Infusion
Description: masked immuno-cytokine comprised of an anti-CD138 IgG1 antibody fused to human interferon alpha 2a
Study NCT05113030 — intervention group
Intervention type: OTHER
Intervention: PERIODONTAL STATUS OF FEMALE PATIENTS WITH PCOS (NEWLY DIAGNOSED) OF ADOLESCENT AGE GROUP WILL BE ASSESSED
Description: Test group(1st) enrollment criteria in PCOS group will be females of adolescent age newly diagnosed with PCOS, with >16 natural teeth. The diagnosis of PCOS will be according to Rotterdam criteria, and periodontal parameters will be recorded to evaluate periodontal status